Table:
begin	end	state
1	17	cytoplasmic
18	40	transmembrane
41	45	non-cytoplasmic
46	66	transmembrane
67	93	cytoplasmic
94	118	transmembrane
119	124	non-cytoplasmic
125	147	transmembrane
148	155	cytoplasmic
156	175	transmembrane
176	202	non-cytoplasmic
203	226	transmembrane
227	246	cytoplasmic
247	265	transmembrane
266	283	non-cytoplasmic
284	305	transmembrane
306	334	cytoplasmic
335	356	transmembrane
357	361	non-cytoplasmic
362	384	transmembrane
385	404	cytoplasmic
405	425	transmembrane
426	430	non-cytoplasmic
431	449	transmembrane
450	466	cytoplasmic

Input:
>RR42_RS05070
MVQREQGLHRSLKPAQLAMIAIGGAIGTGLFMGSGFAIGFAGPGVLLSYAIGALVTLLLM
GCLAEMTVAHPTSGSFGAYAEHYVSPLAGFLVRYAYWASIVLAVGTEVTAVALYMGYWFP
QVPAWFWIVSFSAALILINLVGVGIFGAVEYLFSMVKIVAIVAFILVAAYIVFGAPGSTG
SGAAGAGFHHYTAHGGFLPNGLWGMWVAVIVSIFSYLSIEMIAVAAGEAQDPERAVLQAF
RSTMIRLGLFYLLTLALMLAIVPWNQAGAQKSPFVQVMEAIHVPGAAAIINFVVLIAALS
AMNSQLYITTRTMFSLARAGQAPRSFGEVSKRGIPVRALLLSSIGIALATGLNVFYPGNA
FLLMMAISMFGALFTWFMIFVTHYRFRRQWAAAGNRPLAFRMRGFPLLTLLGAGMMLAIM
LTTLLTDAFRMTLITGIPFLAALSVAYLLRFRHRAAPAPLPANDAA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server